Personal Homepage
of VANDER STICHELE Robert, MD
Scientific activities
Created 19/06/1995 / Last modified 15/06/2004
VANDER STICHELE Robert
Heymans Institute of Pharmacology, Medical School, University
of Gent
De Pintelaan 185, B-9000 Gent, Belgium
Tel. : 00 32 9 240 33 36
Fax. : 00 32 9 240 49 88
E-mail : robert.vandersti
chele@ugent.be
WWW : http:/allserv.rug.ac.be/~rvdstich/
JOURNAL ARTICLES AND BOOK CHAPTERS
R. H. Vander Stichele, M. M. Elseviers, M. Ferech, S. Blot, H. Goossens,
the ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): Data Collection
Performance and Methodological Approach. British Journal of Clinical
Pharmacology. Online publication date: 21-Jun-2004. doi: 10.1111/j.1365-2125.2004.02164.x
Bilsen J, Vander Stichele R, Mortier F, Bernheim J, Deliens L. The
incidence and characteristics of end-of-life decisions by GPs in Belgium.
Family Practice 2004; 21(3):282-289.
Vander Stichele RH, Bilsen JJR, Bernheim JL, Mortier F, Deliens L. Drugs
used for euthanasia in Flanders, Belgium. Pharmacoepidemiology and Drug
Safety 2004; 13(2):89-95.
Deliens L, Ganzini L, Vander Stichele R. The use of drugs to hasten
deaths. Pharmacoepidemiology and Drug Safety 2004; 13(2):113-114. 1.257)
Mortier E, Bilsen J, Vander Stichele RH, Bernheim J, Deliens L. Attitudes,
sociodemographic characteristics, and actual end-of-life decisions of
physicians in Flanders, Belgium. Medical Decision Making 2003;
23(6):502-510.
Vander Stichele R. Information retrieval skills of researchers in general
practice.Eur J Gen Pract. 2003;9:75-6.
Lapeere H, Vander Stichele RH, Naeyaert JM. Evidence in the treatment of
head lice: Drowning in a swamp of reviews. Clinical Infectious Diseases
2003; 37(11):1580-1582. . 5.393)
Ronning M, Blix HS, Strom H, Skovlund E, Andersen M, Vander Stichele R.
Problems in collecting comparable national drug use data in Europe: the
example of antibacterials. European Journal of Clinical Pharmacology 2003;
58(12):843-849.
Rosian I, Vogler S, Vander Stichele R, Larsen L, Odegaard B, Brahm AK et
al. EURO-MED-STAT - Monitoring expenditure and utilization of medicinal
products in the European Union countries: a Public Health approach.
European Journal of Public Health 2003; 13:95-100.
Ferech M, Elseviers M, Vander Stichele R, Goossens H. Consumption of
antibiotics in Europe: Results of the ESAC retrospective data collection.
Value in Health 2003; 6(6):746.
Vander Stichele RH. Bridging the gap between research and policy: focusing
the patient. European Journal of Public Health 2002; 12(4):31.
Vander Stichele RH, Peys F, Van Tielen R, Van Eeckhout H, van Essche O,
Seys B. A decade of growth in public and private pharmaceutical
expenditures: The case of Belgium 1990-1999. Acta Clinica Belgica 2003;
58(5):279-289.
LeLorier J, Vander Stichele RH, Avorn J, Beard K, Hallas J, Henry DA.
Bringing epidemiology into drug utilisation research. Pharmacoepidemiology
and Drug Safety 2003; 12(2):153-156.
Vander Stichele RH, Van Dierendonck A, De Vooght G, Reynvoet B, Lammertyn J.
Impact of benefit messages in patient package inserts on subjective drug perception.
Drug Inform J 2002;26:201-208.
Vander Stichele RH, Gyssels L, Bracke C, Meersschaut F, Blokland I, Wittouck E,
Willems S, De Maeseneer J.
Wet combing for head lice: feasibility in mass screening, treatment preference and effectiveness.
J Roy Soc Med (Accepted).
Deschepper R, Vander Stichele RH, Haaijer-Ruskamp FM.
Cross-cultural differences in lay-attitudes and utilisation of antibiotics in a Belgian and a Ducth City.
Pat Educ Couns (accepted).
Verstraete AG, Vander Stichele RH, Deliens HJ.
Ethical issues in pharmacoepidemiological research in Belgium.
Pharmacoepidemiol Drug Saf 2001;10:595-599.
De Backer TL, Vander Stichele RH, Bogaert MG.
Buflomedil for intermittent claudication.
Cochrane Database Syst Rev 2001;(1):CD000988.
Deliens L, Mortier F, Bilsen J, Cosyns M, Vander Stichele R, Vanoverloop J,
Ingels K, Bernheim J.
[Euthanasia and other medical decisions concerning the end of life in Belgium:
epidemiologic studies] Rev Med Liege. 2001 Jun;56(6):443-52. (French).
De Backer TL, Vander Stichele RH, Warie HH, Bogaert MG.
Oral Vasoactive medications intermittent claudication: utile of futile?
Eur J Clin Pharmacol 2000;56:199-206.
Deliens L, Mortier F, Bilsen J, Cosyns M, Vander Stichele R, Vanoverloop J, Ingels K.
End-of-life decisions in medical practice in Flanders, Belgium: a nationwide
survey.
Lancet. 2000;356:1806-11.
Mortier F, Deliens L, Bilsen J, Cosyns M, Ingels K, Vander Stichele R.
End-of-life decisions of physicians in the city of Hasselt (Flanders, Belgium).
Bioethics 2000;14:254-267.
De Maeseneer J, Blokland I, Willems S, Vander Stichele R, Meersschaut F.
Wet combing versus traditional scalp inspection to detect head lice in schoolchildren:
observational study.
BMJ. 2000;321:1187-8.
Pan L, Vander Stichele R, Rosseel MT, Berlo JA, De Schepper N, Belpaire F.
Effects of smoking, CYP2D6 genotype and concomitant drug intake
in the steady state plasma concentrations of haloperidol and reduced haloperidol
in schizophrenic inpatients. Ther Drug Mon 1999;21:489-497.
Van Wynckel M, Vander Stichele R, De Bacquer D, Bogaert MG.
Use of laxatives in institutions for the mentally retarded.
Eur J Clin Pharmacol 1999;54:965-69.
De Sutter K, Vander Stichele R, Vander Stichele RH, Robays H.
[Follow up of quality of drug distribution systems in the hospital].
Hospitalia, 1998;1:38-49.
Vander Stichele RH. [Polypharmacy in the elderly]. Bijblijven 1998;2:43-42 (Dutch).
Vander Stichele RH, De Potter B, Vyncke P, Bogaert MG.
Attitude of physicians toward patient package inserts for
medication in Belgium. Pat Educ Counsel 1996;28:5-13.
Vander Stichele RH, Bogaert MG. Topical treatments for head
lice. Authors' reply. [Comment] BMJ 1996;312:123.
Vander Stichele RH, Bogaert MG. Clinical efficacy of treatment
of head lice. Authors reply. [Comment] BMJ 1995;311:1369-
1370
Vander Stichele RH, Dezeure E, Bogaert MG. A systematic
review
of clinical efficacy of topical treatments of head
lice. BMJ 1995;311:604-8.
Vander Stichele RH, Petri H. Utilization of subsidized and
nonsubsidized reimbursable peptic ulcer medication in
Belgium.
Pharmacoepidemiology and Drug Safety 1995;4:213-24.
Bogaert MG, Vander Stichele R. [Factors influencing
medication
prescription]. Louvain Med 1995;114:320-324.(French).
Vander Stichele RH, Bogaert MG. Pediculus Humanus Capitits
in
schoolchildren [letter]. Lancet 1995;345:731.
Vander Stichele RH, Bogaert MG. European legislation and
research projects regarding patient education for
medication.
Drug Inform J 1995;29:285-290.
Bogaert MG, Vander Stichele R. Drug treatment: risk
perception
by the public and the health professionels. Eur J Clin Res
1994;6:203-13.
Bogaert MG, Vander Stichele R. [Pharmacokinetics and
Pharmacodynamics of cardiovascular drugs in women].
Tijdschr
Geneesk 1994;50:989-992 (Dutch).
Bogaert MG, Vander Stichele R. [Medication usage by the
elderly]. Tijdschr voor Geneeskunde 1993;49:1668-1670.
Vander Stichele RH, Mestdagh J, Van Haecht CHM, De Potter
B,
Bogaert MG. [Medication utilization and patient information
in
homes for the aged]. Huisarts Nu 1993;23:10-16 (Dutch).
Vander Stichele RH. [Studies on the interface between
primary
care and hospital in medication utilization]. Pharmacon
1992;92:139-145 (Dutch).
Petri H, Vander Stichele R, Cuypers J. [Use of reimbursed
anti
ulcer therapy]. Apothekersblad 1992(12):16-21 (Dutch).
Vander Stichele RH, Thomson M, Verkoelen K, Droussin AM.
Measuring patient compliance with electronic monitoring:
lisinopril versus atenolol in essential hypertension. Post
Marketing Surveillance 1992;6:77-90.
De Cort P, Vander Stichele R, Janssen M, Heyrman J.
[Quality
of life in hypertensive patients]. Huisarts Nu
1992;22:378-382.
(Dutch).
Vander Stichele RH, Van Elsen J, Lannoy J, Riebbels G.
[Interprofessional relations between general
practititioners
and other health professionals in an urban region.]
Tijdschr
Geneeskd 1992;48:847-855) (Dutch).
Vander Stichele RH, Mestdagh J, Van Haecht CHM, De Potter
B,
Bogaert MG. Medication utilization and patient information
in
homes for the aged. Eur J Clin Pharmacol 1992;43:319-321
Vander Stichele RH, Van Haecht CH, Braem MD, Bogaert MG.
Attitude
of the public towards technical package inserts for
medication
information in Belgium. DICP 1991;25:1002-1006.
Vander Stichele R. Measurement of patient compliance and
the
interpretation of randomized clinical trials. Eur J Clin
Pharmacol 1991;41:27-35.
Van haecht CHM, Vander Stichele R, De Backer G, Bogaert
MG.
Impact of Patient Package Inserts on Patients'
Satisfaction,
Adverse Drug Reactions and Risk Perception: The Case of
NSAIDs
for posttraumatic Pain Relief. Pat Educ Counsel
1991;17:205-
215.
Staessen J, Bogaert M, Clement D, Dekempeneer L, De Plaen
JF,
Fagard R, Heyrman J, Lijnen P, Pelemans W, Thijs L, Vander
Stichele R, Van Hoof R, Amery A. [Isolated Systolic
Hypertension in the elderly. Part I : Epidemiology,
pathophysiology and diagnosis. Tijdschr Geneeskd
1991;47:561-
570 (78 ref.) (Dutch).
Staessen J, Bogaert M, Clement D, Dekempeneer L, De Plaen JF,
Fagard R, Heyrman J, Lijnen P, Pelemans W, Thijs L, Vander
Stichele R, Van Hoof R, Amery A. [Isolated Systolic
Hypertension in the elderly. Treatment]. Tijdschr Geneeskd
1991;47:609-619 (97 ref.) (Dutch).
Vander Stichele R. Patient package inserts: carriers of
consensus information. In: Dinkel R, Horisberger B, Tolo
KW
(eds). Improving drug safety - a joint responsability.
Berlin:
Springer-Verlag, 1991:151-155.
Van haecht CHM, Vander Stichele R, Bogaert MG. Package
inserts
for antihypertensive drugs: use by the patients and impact
on
adverse drug reactions. Eur J Clin Pharmacol
1990:39:551-554.
Vander Stichele R, Bogaert MG. Patient package inserts:
the
Belgian experience with a mandatory program. Drug Inform J
1989;23:673-677.
Vander Stichele R. Patient package inserts as a source of
drug
information: review of the literature. In: Bogaert M,
Vander
Stichele R, Kaufman JM, Lefebvre R (eds). Patient package
insert as a source of drug information. Amsterdam:
Excerpta
Medica, 1989:3-11.
Peeters C, Vander Stichele R. A training course in medical
documentation for family physicians. In: Deschamps C,
Walckiers M (eds). Medical libraries: cooperation and new
technologies. Elsevier Science Publishers, North-Holland,
1987.
Vander Stichele RH, Verhellen E. [Medical Documentation
for
Family Physicians]. Part 2. Teacher's manual. State
University
of Gent, Department of Adult Education, 1986 (Dutch).
Vander Stichele RH, Verhellen E. [Learning to deal with
scientific literature]. Proceedings of a symposium of the
Belgian Fund for Scientific Research. State University of
Gent, Department of Adult Education, 1985 (Dutch).
Verhellen E, Vander Stichele RH. [Medical Documentation
for
Family Physicians]. Part 1. Program report. State
University
of Gent, Department of Adult Education, 1985 (Dutch).
Vander Stichele R, Heyvaert J, Van Royen P, De Smet E.
[Information channels to the flemish general
practitioner].
Huisarts Nu, 1985;14(5):188-195 (Dutch).
Vander Stichele RH. [Zomepirac and anaphylaxis: a study of
the
role of medical literature in the reporting of serious
side-
effects of new medicines]. Huisarts Nu, 1983;12(5):164-166
(Dutch).
ACKNOWLEDGMENTS IN OTHER PUBLICATIONS
Detry JMR, Block P, De Backer G, De Gaute JP, Six R (The
Belgian Collaborative Study Group). Patient compliance and
therapeutic coverage: comparison of amlodipine and slow
release nifedipine in the treatment of hypertension. Eur J
Clin Pharmacol 1995;47:477-81.
Detry JMR, Block P, De Backer G, De Gaute JP, Six R (The
Belgian Collaborative Study Group). Patient compliance and
therapeutic coverage: amlodipine versus slow release
nifedipine in the treatment of agina pectoris. J Int Med
Res
1994;22:278-286.
EDITING OF BOOKS
De Schepper R, Vander Stichele R, Mortier F, Deliens L, Zorgzaam thuis
sterven - Een zorgleidraad voor huisartsen. Gent, Academia Press, 2003
[Dutch]
Buntinx F, Vander Stichele R. Omgaan met medische
documentatie
en informatie. Leuven: ACCO, 1998 [Dutch].
Buntinx F, Vander Stichele R. Omgaan met medische
documentatie
en informatie. Antwerpen: Wetenschappelijke Vereniging van
Vlaams Huisartsen Instituut, 1993 [Dutch].
Vander Stichele R, Van Peteghem S, Buntinx F (eds).
[Medical
and Nursing Libraries in Belgium]. Flemish Research
Institute
of Family Medicine, 1989 (Dutch).
Bogaert M, Vander Stichele R, Kaufman JM, Lefebvre R
(eds).
Patient package insert as a source of drug information.
Amsterdam: Excerpta Medica, 1989.
Robert H. VANDER STICHELE
Family Physician Last Update : June 8th, 2002
Age 49
Married (Van den Berghe Maria)
2 children
Heymans Institute of Pharmacology Tel. : +32 9 240 33 36
De Pintelaan, 185 Fax. : +32 9 240 49 88
B-9000 Gent
Belgium
EDUCATION
Medical Doctor, State University of Gent and Free
University
of
Brussels, Belgium, 1977.
ECFMG-Certificate, Brussels, 1977.
MAIN OCCUPATION
February 1978 - Present :Practicing family physician in
the city of Gent, Belgium.
EXPERIENCE
November 20001 - Present : Senior Researcher, Centre for Evidence Based Medicine,
Belgian Branch of the Cochrane Collaboration, Ghent University.
October 2000 - Present : Senior Researcher, Guidelines for End-of-life decisions,
Ghent University, Department of Philosophy.
April 1999 - Present : Coordinator of Information Technology Applications,
Belgian Centre of Pharmacotherapeutic Information, Brussels.
March 2002 - January 2004 : Network Coordinator, European
Surveillance
of Antimicrobial Consumption, Departement of Microbiology, University of Antwerp.
July 1996 - July 2000 : Senior Researcher, Health
Technology Assessment, Heymans Institute of Pharmacology and
the Belgian Supreme Council for Health Care, Brussels.
October 1995 - June 1996 : Research Coordinator, Drug
Utilization Review, Heymans Institute of Pharmacology, Ghent University.
January 1995 - September 1995 : Research Coordinator of
the Institute of Pharmaco-epidemiology of Belgium, Brussels.
September 1993 - December 1994 : Coordinator of the
Meta-analysis Project, Heymans Institute of Pharmacology, Ghent
University.
March 1988 - August 1993 : Chief coordinator of the
Belgian Patient Package Insert Evaluation Program, Heymans
Institute of Pharmacology, Ghent University.
December 1987 - January 1991 : Proofreader of Patient
Package Inserts for the Pharmaceutical Inspection of the Belgian
Department of Health.
February 1986 - November 1987 : Special Advisor to the
Belgian
State Secretary of Health on biomedical ethical issues and
medication information policy.
January 1984 - December 1985 : Chief coordinator of
the
educational research program "Bibliographic Instruction
for
Family Physicians", Department of Adult Education, State
University of Gent.
PUBLIC SERVICE, Robert H. VANDER STICHELE
Member of the board of the European Drug Utilization Research
Group (1996-present)
Member of the board of the Belgian Society of Pharmaco-
epidemiology (1995-present)
Editorial Board, Patient Education and Counseling
(1994-present)
Acting Secretary General, the Institute of
Pharmacoepidemiology
of Belgium (1990-1995).
Coordinator, the Medical Subject Headings Dutch
Translation
Program, Institute of Translators and Interpretors, Gent,
Belgium
(1988-present).
Visiting lecturer, Free University of Brussels, Masters &
PhD
Program of Pharmaceutical Medicine, partim "Drug
Utilization
Review" (1994-present).
Visiting lecturer, Medical School of the State University
of
Gent, on the subject of Medical Documentation
(1986-present).
Acting Secretary General, the Flemish Research Institute
of
Family Medicine (1985-1995).
Editorial Board, Huisarts Nu (1985-1993).
Project Manager for the glossary of technical and popular
medical
terms in nine European languages, contracted by the
Commission
of
the European Communities (DG III) (1993-1995)
Editiorial Board, Post Marketing Surveillance. An
International
Journal devoted to Pharmacoepidemiology. (1991-1994).
Coordinator, the European Directory of Medical Libraries
Program,
European Association of Health Information and Libraries
(1989-
1990).
Copromotor of dissertations, the Postgraduate of
Documentation
and Library Science, University of Antwerp (1986-1988).
Reviewer for Patient Education and Counseling, British
Journal
of
General Practice, Annals of Pharmacotherapy, Postmarketing
Surveillance: the International Journal of
Pharmacoepidemiology.
PARTICIPATIONS, Robert H. VANDER STICHELE
Participated at the Food and Drug Adminstration Patient
Information Workshop (panel discussion), Washington DC,
February 14-15, 1996.
Participated at the 3th annual Meeting of the Belgian Society
for Pharmaco-epidemiology, Liege, Belgium, November 17, 1995.
Participated at the 2th annual Meeting of the Belgian
Society
for
Pharmaco-epidemiology, Brussels, Belgium, November 19,
1994
Chaired a session at the 12th annual meeting of Flemish
General
Practice Research, Antwerp, Belgium, September 24, 1994.
Chaired a session "The European Directive on Patient
Package
Inserts: Implications for the US", at the 30th Annual
Meeting
of the Drug Information Association, "Health care systems
in
transition: a challenge for innovation"., Washington DC,
USA,
June 5-9, 1994.
Convened the International Congress "Pharmacoeconomics",
European
Society for Clinical Pharmacy and European Society for
Hospital
Pharmacists, Gent, Belgium, May 18-20, 1994
Participated at the Symposium "Growing older : medical and
social
aspects" of the Department of Medicine, University of
Gent,
December 11, 1993.
Participated at the Drug Information Association
Euro-meeting
"Interfaces in drug discovery, development and use:
Reappraisal
in an era of change", London, United Kingdom, October 10-
13,1993.
Convened and organized the Heymans Institute Symposium
"Pharmacoepidemiology in Belgium", 1th Annual Meeting of
the
Belgian Society for pharmacoepidemiology, Gent, Belgium,
October 9, 1993
Convened and organized the Heymans Institute Symposium
"From
Belgian Patient Package Inserts to European User Package
Leaflets.", Gent, Belgium, April 28, 1993.
Participated at the Drug Information Association Workshop
"Patient information and education about prescription
drugs".
Washington, DC, USA, November 18-19, 1992.
Participated at the Drug Information Association Workshop
"Non-
complier or Non-responder ?". Bern, Switzerland, May
18-19,
1992.
Participated at the international symposium "The importance
of
therapeucic coverage". Pfizer, Basel, Switzerland,
February
14,
1991.
Participated at the symposium "[European future of research
in
general practice]". Janssen Research Group, Beerse,
Belgium,
June 16, 1990.
Participated at the International Dialogue Conference
"Improving
drug safety - A joint responsability", RAD-AR Foundation,
Wolsfsberg, Switzerland, April 17-20, 1990.
Participated at the Workshop "The impact of partial
compliance
on
clinical trials", Drug Information Association,
Philadelphia,
USA, September 18-19, 1989.
Participated at the 25th annual meeting of the Drug
Information
Association "Challenges of drug discovery, global
development
and marketing in the 1190s", Drug Information Association,
Boston, USA, June 19-22, 1989.
Participated at the Internation Congres on Primary Health
Care
"Research Methods for Primary Health care", European
General
Practice Research Workshop, Antwerp, Belgium, October 21,
1988.
Convened and organized the symposium "Patient package
inserts
as
a source of written drug information", Heymans Institute
of
Pharmacology, Gent, Belgium, September 26-28, 1988.
Organized the symposium "[Bio-ethics in the ninenties]",
State
Secretary of Health, Brussels, Belgium, May 21-22, 1987.
Participated at the First European Conference of Medical
Libraries "Medical Libraries: cooperation and new
technologies", European Association of Health Information
and
Libraries, Brussels, Belgium, October 22-25, 1986.
Chaired the Symposium "Learning to deal with scientific
information", Belgian Fund for Scientific Research,
Brussels,
Belgium, November 8, 1985.
Vander Stichele RH, Deschepper R, Communication about end-of-life decisions with patients dying at home: development of guidelines for general practitioners. WONCA Europe Regional Conference, Amsterdam, 1-4 June, 2004. (Poster)
Deschepper R, Vander Stichele R, Bernheim JL, Mortier F, Deliens L. Guidelines on end-of-life care and communication: Do they include the patients' point of view? 3th Research Forum of the European Association for Palliative Care, Stresa, Lago Maggiore, Italy, 3-6 June, 2004. (Poster)
Deschepper R, Vander Stichele R, Mortier F, Deliens L et al. Communication about end-of-life decisions with patients dying at home: development of guidelines for general practitioners, Vierde Eerstelijnssymposium: De patiënt centraal, WVVH, 27 September 2003. (Poster)
Vander Stichele RH. European Surveillance of antimicrobial Consumption: Quality Indicators. 6th Congress of the European Association of Clinical Pharmacology and Therapeutics, Istanbul, 24 - 28 June, 2003. (Poster)
Ferech M, Vander Stichele RH, Elsevier M, Goossens H. An exploration of the Therapeutic arsenals of antibiotics in European countries using the Drug Utilization 90% method. 6th Congress of the European Association of Clinical Pharmacology and Therapeutics, Istambul, 24 - 28 June, 2003. (Poster)
Elsevier M , Vander Stichele RH, Ferech M, Goossens H. Regional clusters in antibiotic consumption in Europe. 6th Congress of the European Association of Clinical Pharmacology and Therapeutics, Istanbul, 24 - 28 June, 2003. (Poster)
Vander Stichele RH, Elseviers M, Ferech M, Goossens H. Data collection performance in the European surveillance of antibiotic consumption. Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)
Ferech M, Elseviers M, Vander Stichele RH, Goossens H. Methodological problems encountered in the European surveillance of antibiotic consumption. Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)
Elseviers M, Ferech M, Vander Stichele RH, Goossens H. Consumption of antibiotics in ambulatory care in Europe: Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)
Elseviers M, Ferech M, Vander Stichele RH, Goossens H. Consumption of antibiotics in hospital care in Europe: Results of the retrospective data collection 1997-2001. 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003. (On invitation)
Goossens H, Vander Stichele RH, Elseviers M, Ferech M. Consumption of antibiotics in [26 European countries]. Results of the retrospective data collection 1997-2001 (Poster session with 26 posters). 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 10-13 May, 2003.
Bernheim J, Deschepper R, Mortier F, Vander Stichele R, Deliens L. Information and Communication Agreements (ICA) to harmonise Patient autonomy and physician beneficence at the end of life. 8th Congress of the European Association for Palliative Care in The Hague, The Netherlands, 2-5 April, 2003. (Poster)
Deschepper R, Bernheim J, Ceulemans L, Mortier F, Van Der Kelen G, Vander Stichele R, Deliens L. Communication about end-of-life decisions with patients dying at home: development of guidelines for general practitioners. 8th Congress of the European Association for Palliative Care in The Hague, The Netherlands, 2-5 April, 2003.
(Presentatie)
Van Der Kelen G, Deschepper R, Vander Stichele R, Bernheim J, Ceulemans L, Mortier F, Deliens L. The changing position of the general practitioner in the end-of-life care : The patient's perspective. 8th Congress of the European Association for Palliative Care in The Hague, The Netherlands, 2-5 April, 2003. (Poster)
Bilsen J, Vander Stichele R, Deliens L, Mortier F, Mortier E. Life-Terminating Drugs Used by Belgian Physicians in End-of-Life Decisions Not Requested by Terminal Patients. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)
Ronning M, Blix HS, Strom H, Vander Stichele R, Andersen M, Skovlund E. Use of antibacterials in Europe: A study on collecting comparable National Drug Use data in Europe. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)
Hejdova M, Gorecka K, Lindhartova A, Kucera Z, Zemkova M, Vlcek J, Vander Stichele R. Drug Utilization Studies at International Conferences of Pharmacoepidemiology, 1996-2001. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Presentation)
Elsevier M, Vander Stichele R, Hendrix E, Goossens H. A European funded project on antimicrobial consumption (ESAC): Availability and accessability of antibiotic consumption data in European countries. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)
Vander Stichele R, Elsevier M, Hendrix E, Seys B, Goossens H. Comparing Belgian Antibiotic consumption data: methodological problems. 18th International Conference on Pharmaco epidemiology, Edinburgh, 20-23 August, 2002. (Poster)
Bernheim J, Cosyns M, De Bock R, De Grève J, Deliens L, Distelmans W, Mathys R, Mortier E, Mortier F, Schots E, Vander Stichele R. The patient-physician information contract: a solution to the dilemma between patient autonomy and physician paternalism, Winter Oncology Conference 7, Flims - Switserland, 21-27 january 2001.
(Poster)
Vander Stichele RH. Co-operation between drug information centres (DICs) and Drug Utilization Research Groups (DURGs) on the national level. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Presentatie)
De Schepper R, Vander Stichele RH. Different use of antibiotics in Europe: The role of cultural factors. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Poster)
Vander Stichele RH, Bossens M, De Falleur M, Seys B, Elseviers M. Utilization of antibiotics in Belgium. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Poster)
Vander Stichele RH, Meerschaut F, Blocklandt I, Wittouck E, Demaeseneer J. A pilot study of a community approach to the control of head lice infestation in 3 inner city primary schools in Belgium. EuroDURG Meeting 2001, Prague, 7 - 9 June, 2001. (Poster)
Vander Stichele R, Deliens L., Bilsen J, Deschepper R. Utilization of euthanatica in Belgium: results of a death certificate study. 16th International Conference on Pharmaco epidemiology, Barcelona, 20-23 August 2000. (Poster)
Deschepper R, Vander Stichele R. Antibiotics utilization and the cultural context - An antropological investigation of the lay perspective in a Dutch and a Belgian city. 16th International Conference on Pharmaco epidemiology, Barcelona, 20-23 August 2000. (poster)
Deschepper R, Vander Stichele R, Mortier F, Bilsen J. End-of-life decisions of clinical specialists and GP's in Belgium (Flanders). 3th Conference of death, dying and suicide, Stockholm, 28-30 August 2000. (Poster)
Vander Stichele RH. Dose omissions and their consequences.
European Association of Clinical Pharmacology and Therapeutics, Jeruzalem, October 4-6, 1999.
Deliens L, Bilsen J, Cosyns M, Ingels K, Mortier F, Vander Stichele R, Handelwijzen van Hasseltse huisartsen rond het levenseinde van patiënten, in: congresbundel van de 17de VHI-referatendag, te Antwerpen, Vlaams Huisartsen Instituut, 25 September, 1999. (Poster)
Deliens L, Mortier F, Bilsen J, Cosyns M, Ingels I, Vander Stichele R, Attitudes and behaviour of physicians concerning end-of-life decisions, conference proceedings 15th Nordic Conference on Social Medicine, Reykjavík - Iceland, 3-5 Juni 1999. (Poster)
Bilsen J, Deliens L, Cosyns M, Ingels K, Mortier F, Vander Stichele R, The patient-doctor relationship in end-of-life decisions in Belgium, conference proceedings Annual Meeting of EUPHA, Göteborg - Sweden, 10-12 December 1998. (Poster)
Mortier F, Deliens L, Bilsen J, Cosyns M, Ingels K, Vander Stichele R, End-of-life acts of doctors in Belgium (Flanders): a research design for a national survey, conference proceedings 12th International Conference of the "World Federation of Right to Die Societies", Zürich, 12 ? 15 October 1998. (Poster)
Vander Stichele RH, De Vooght G, Lammertyn J, Reynvoet B, Vandierendonck A. Impact of benefit information in patient package inserts on patients' perception of risk/benefit of medicines. 14th International Conference on Pharmacoepidemiology, Berlin, 16-19 August, 1998. (Poster)
Deliens L, Bilsen J, Cosyns M, Ingels K, Mortier F, Vander Stichele R, End-of-life acts of GP's and specialists in Belgium, conference proceedings 15th WONCA World Conference, Dublin - Ireland, 14-18 Juni 1998. (Presention)
Deliens L, Bilsen J, Cosyns M, Ingels K, Mortier F, Vander Stichele R, Behaviour of doctors concerning the end-of-life of their patients. Results of a survey of 269 deaths in the city of Hasselt (Belgium), conference proceedings Annual Meeting of EUPHA, Pamplona - Spain, 20-22 November 1997. (Poster)
Presented "Collection and analysis of comprehensive data on
Utilization of reimbursed medicines in Belgium" at the first
European Drug Utilization Research Group Meeting, Lake
Balaton, Hungary, June 29, 1996.
Presented "The influence of copayment and reimbursement policy
on drug Utilization" at the University of Gent, 80st
Continuing Medical Education Course, Gent, Belgium, June 5,
1996.
Presented "Compliance measurement, Data expression and
analytical strategy : 5 delusions and 5 promises", at the
University of Limburg, Departement of Epidemiology "Lowlands
workshop on patient compliance", Maastricht, The Netherlands,
May 13, 1996
Presented "Working with drug utilization monitoring data
[Dutch]", at a joint symposium of the Scientific Association
of the Flemisah General Practitioners and the Royal
Association of Pharmacists of Antwerp "Analysing prescription
behavior", Antwerp, Belgium, February 10, 1996
Presented "The prescription of medicines and the pharmacist-
physician interaction", at the IVth European Forum for
Pharmaceutical education, Brussels, Belgium, December 11,
1995.
Presented "Drug Utilization in the Elderly", at the 1st
Congress of the European Association for Clinical Pharmacology
and Therapeutics, Paris, France, September 28, 1995 (With
Bogaert MG)
Presented "Side effects of medicines and partial compliance :
two related impediments to the quality of prescription drug
therapy", at the 31th annual Meeting of the Drug Information
Association "The changing regulatory environment and its
impact on global healthcare", Orlando, Florida, USA,
June 25-29, 1995.
Prestented "The life of a drug : from birth to obsolence", at
IBC-Conference, "New drug safety guidelines,: collecting the
information, taking the right decision", Brussels, Belgium,
April 25, 1995.
Presented "Investigator views and experience regarding
"guidelines for retention of clinical trial records at
investigator sites", at the Second Annual Conference of the
European Forum for Good Clinical Practice,."Common sense in
GCP - an EFGCP debate -". Brussels, Belgium, March 29, 1995.
Presented "Medication Utilization, information and
expenditure
of
frail elderly living at home", 2th annual Meeting of the
Belgian Society for Pharmaco-epidemiology, Brussels,
Belgium,
November 19, 1994
Presented "Attitude of health Professionals towards
patient
package inserts", 30th Annual Meeting of the Drug
Information
Association, "Health care systems in transition: a
challenge
for innovation"., Washington DC, USA, June 5-9, 1994.
Presented "How to influence prescribing by primary care
physicians?", International Congress "Pharmacoeconomics",
Gent,
Belgium, May 18-20, 1994.
Presented "Drug Utilization Evaluation: the contribution
of
the
community pharmacists to the control of expenditures for
pharmaceuticals. International Congress
"Pharmacoeconomics",
Gent, Belgium, May 18-20, 1994
Co-presented "Drug treatment: risk perception by the
public
and
the health professionels" at the 8th international
conference
of Pharmaceutical Medicine,"Drug developement in the
nineties:
a global commitment". Rome, Italy, April 27-29, 1994 (with
Bogaert MG).
Presented "Prescription patterns in general practice and
attitudes of family physicians towards written medication
information", at a workshop of the Dutch Institute of
Pharmaceutical marketing, Gent, Belgium, December 16, 1993
[Dutch].
Co-presented "The elderly and medication utilization and
information" at a symposium of the Departement of
Medicine,
Gent, Belgium, December 11, 1993 (with Bogaert MG)
[Dutch].
Presented "Participation of general practitioners in
clinical
trials", at a symposium of the Flemish Research Institute
of
General Practice, october 26, 1993 [Dutch].
Presented "European legislation and research projects
regarding
patient education for medication" at the Euro-DIA meeting,
October 12, 1993.
Co-presented "The use of K-Dimensional computer storage
and
retrieval Systems for pharmacoepidemiological analysis of
billing data on reimbursed medication in Belgium" at the
Heymans Institute Symposium "Pharmacoepidemiology in
Belgium",
Gent, Belgium, October 9, 1993 (with P. Lehert).
Presented "Utilization of subsidized and nonsubsidized
reimbursable peptic ulcer medication in Belgium" at the
Heymans
Institute Symposium "Pharmacoepidemiology in Belgium",
Gent,
Belgium, October 9, 1993 (with H. Petri).
Presented "Medication information and utilization among
socially
active elderly", at the Annual Meeting of the Flemish
Research
Institute, Gent, Belgium, September 18, 1993 [Dutch].
Co-presented "The impact of the European Community's 1992
regulations on patient information through the package
leaflet", at the annual meeting of the Royal Society of
Medicine, London, United Kingdom, September 16, 1993 (with
MG.
Bogaert).
Presented "Time intervals between medication events: an
approach
to measurement of patient compliance with data from
electronic
monitoring" at a seminar in the University of Limburg,
Statistical department, Diepenbeek, Belgium, September 9,
1993.
Presented "Belgian and European research projects on
patient
package inserts", at the Heymans Institute Symposium "From
Belgian Patient Package Inserts to European User Package
Leaflets.", Gent, Belgium, April 28, 1993.
Presented "Computerized readability control of patient
package
inserts in Belgium" at the 3rd Computer Workshop
"Information
technology for the registration and surveillance of
medicinal
products", organized by the Regulatory Affairs
Professionals
Society Europe and the Commission of the European
Community,
Brussels, Belgium, February 23-24, 1993 (with MG.
Bogaert).
Presented "Patient compliance and therapeutic coverage:
implications of the pharmacokinetics of amlodipine." at a
satellite symposium of the 12th annual scientific meeting
of
the Belgian Society of Cardiology, Brussels, Belgium,
February
4, 1993.
Presented "1994 EEC regulations: plans and research
experiences
with patient information and education" at the Food and
Drug
Administration, Center for drug evaluation and research,
Advanced Scientific Education Seminar, Rockville,
Maryland,
USA, November 20, 1992.
Presented "Review and update on European initiatives
regarding
patient education for medication" at the Drug Information
Association Workshop, Washington, DC, USA, November 18,
1992.
Presented "Studies of the interface between primary care
and
hospital care in drug utilization" at the Annual Meeting
of
the
Flemisch Association of Hospital Pharmacists, Gent,
Belgium,
April 28, 1992.
Presented "New medications to face the reality of
pharmacotherapy
in general practice." for Phizer, Finland, in Brussels,
Belgium, March 27, 1992.
Presented "Impact of Patient Package Inserts on Patients'
Satisfaction, Adverse Drug Reactions and Risk Perception:
The
Case of NSAIDs for posttraumatic Pain Relief" at the
Annual
Meeting of the Flemish Research Institute of Family
Practice,
Kortrijk, Belgium, June 15, 1991.
Presented "Network of Patchwork? Citation Analysis of 6
international Research Journals in Family Medicine" at the
Annual Meeting of the Flemish Research Institute of Family
Practice, Kortrijk, Belgium, June 15, 1991.
Presented "Written drug information in patient package
inserts;
the Belgian drug information program and evalutation
research
project" at the Continuing Medical Education Course of
Clinical
Pharmacology, University of Louvain, Belgium, March 14,
1991.
Presented "New medications to face the reality of
pharmaco-
therapeutics in General Practice" to a Pfizer symposium,
Basel,
Switzerland, Februari 14, 1991.
Presented "General practitioner and pharmacist: the role
of
primary health care clinicians in clinical research" at a
symposium of the Royal Association of Pharmacists of
Antwerp,
Belgium, October 24, 1990.
Presented "Fitting research in general practice into Good
Clinical Practice" to the symposium of the Janssen
Research
Group, Beerse, Belgium, June 16, 1990.
Presented "A carrier of consensus on medication information
:
the patient package insert" at the International Dialogue
Conference of the RAD-AR Foundation, Wolsfsberg,
Switzerland,
April 17-20, 1990.
Presented "Patient package inserts: the Belgian experience
with a
mandatory progrma" at the 25th annual meeting of the Drug
Information Association, Boston, USA, June 19-22, 1989.
Presented "Action research and medical documentation in
primary
health care" at the International Congres on Primary
Health
Care of the European General Practice Research Workshop,
Antwerp, Belgium, October 21, 1988.
Presented "Patient package inserts as a source of drug
information: review of the literature" at the symposium of
the
Heymans Institute of Pharmacology, Gent, Belgium,
September
26-
28, 1988.
Presented "A training course in medical documentation for
family
physicians" to the first European Conference of the
European
Association of Health Information and Libraries, Brussels,
Belgium, October 22-25, 1986.
Presented "Citation-analysis of family medicine literature"
at
the 5th annual meeting of the Flemish Research Institute
of
Family Medicine, Brussels, Belgium, April 19, 1986.
Presented "Learning to deal with scientific information:
con-
cluding remarks" to the symposium of the Belgian Fund for
Scientific Research, Brussels, Belgium, November 8, 1985.
Scientific awards
1992 Upjohn Award for best flemish general practice
research
article in the international literature (see: Patient
Education and Counseling, 1991).
Science must be explained as simple as possible,
but not simpler.
Albert Einstein
L'homme a inventé la parole pour cacher ses idé
es.
De Talleyrand
If I have seen further, it is by standing on the shoulders
of
giants.
Isaac Newton
If I have not seen further, it is by standing in the
footprints of giants.
Unknown student
The nice thing about standards is that there are so many to
choose from.
Andy Tanebaum
